{"denomUnitsSelected":"Participants","description":"To determine if relevant biomarkers correlate with response to treatment in each of the two arms. Unstained sections of tumor tissue will be used for mTOR pathway (including phosphorylated S6 ribosomal protein, PTEN, total and phosphorylated AKT, total and phosphorylated mTOR, and phospho-ERK1/2) immunohistochemistry","reportingStatus":"NOT_POSTED","timeFrame":"At study entry","title":"mTOR Pathway Immunohistochemistry","type":"OTHER_PRE_SPECIFIED"}